T Donker1, J Wallinga2, H Grundmann3. 1. Department of Medical Microbiology, University Medical Centre Groningen, University of Groningen, The Netherlands; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands. Electronic address: t.donker@umcg.nl. 2. Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands. 3. Department of Medical Microbiology, University Medical Centre Groningen, University of Groningen, The Netherlands; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Abstract
BACKGROUND: Patients who seek treatment in hospitals can introduce high-risk clones of hospital-acquired, antibiotic-resistant pathogens from previous admissions. In this manner, different healthcare institutions become linked epidemiologically. All links combined form the national patient referral network, through which high-risk clones can propagate. AIM: To assess the influence of changes in referral patterns and network structure on the dispersal of these pathogens. METHODS: Hospital admission data were mapped to reconstruct the English patient referral network, and 12 geographically distinct healthcare collectives were identified. The number of patients admitted and referred to hospitals outside their collective was measured. Simulation models were used to assess the influence of changing network structure on the spread of hospital-acquired pathogens. FINDINGS: Simulation models showed that decreasing the number of between-collective referrals by redirecting, on average, just 1.5 patients/hospital/day had a strong effect on dispersal. By decreasing the number of between-collective referrals, the spread of high-risk clones through the network can be reduced by 36%. Conversely, by creating supra-regional specialist centres that provide specialist care at national level, the rate of dispersal can increase by 48%. CONCLUSION: The structure of the patient referral network has a profound effect on the epidemic behaviour of high-risk clones. Any changes that affect the number of referrals between healthcare collectives, inevitably affect the national dispersal of these pathogens. These effects should be taken into account when creating national specialist centres, which may jeopardize control efforts.
BACKGROUND:Patients who seek treatment in hospitals can introduce high-risk clones of hospital-acquired, antibiotic-resistant pathogens from previous admissions. In this manner, different healthcare institutions become linked epidemiologically. All links combined form the national patient referral network, through which high-risk clones can propagate. AIM: To assess the influence of changes in referral patterns and network structure on the dispersal of these pathogens. METHODS: Hospital admission data were mapped to reconstruct the English patient referral network, and 12 geographically distinct healthcare collectives were identified. The number of patients admitted and referred to hospitals outside their collective was measured. Simulation models were used to assess the influence of changing network structure on the spread of hospital-acquired pathogens. FINDINGS: Simulation models showed that decreasing the number of between-collective referrals by redirecting, on average, just 1.5 patients/hospital/day had a strong effect on dispersal. By decreasing the number of between-collective referrals, the spread of high-risk clones through the network can be reduced by 36%. Conversely, by creating supra-regional specialist centres that provide specialist care at national level, the rate of dispersal can increase by 48%. CONCLUSION: The structure of the patient referral network has a profound effect on the epidemic behaviour of high-risk clones. Any changes that affect the number of referrals between healthcare collectives, inevitably affect the national dispersal of these pathogens. These effects should be taken into account when creating national specialist centres, which may jeopardize control efforts.
Authors: M Lindqvist; B Isaksson; J Swanberg; R Skov; A R Larsen; J Larsen; A Petersen; A Hällgren Journal: Eur J Clin Microbiol Infect Dis Date: 2015-03-27 Impact factor: 3.267
Authors: Kai Zhou; Mariette Lokate; Ruud H Deurenberg; Marga Tepper; Jan P Arends; Erwin G C Raangs; Jerome Lo-Ten-Foe; Hajo Grundmann; John W A Rossen; Alexander W Friedrich Journal: Sci Rep Date: 2016-02-11 Impact factor: 4.379
Authors: Sandra Reuter; M Estée Török; Matthew T G Holden; Rosy Reynolds; Kathy E Raven; Beth Blane; Tjibbe Donker; Stephen D Bentley; David M Aanensen; Hajo Grundmann; Edward J Feil; Brian G Spratt; Julian Parkhill; Sharon J Peacock Journal: Genome Res Date: 2015-12-15 Impact factor: 9.043
Authors: Cheryl L Gibbons; Bram A D van Bunnik; Oliver Blatchford; Chris Robertson; Thibaud Porphyre; Laura Imrie; Julie Wilson; J Ross Fitzgerald; Mark E J Woolhouse; Margo E Chase-Topping Journal: BMC Infect Dis Date: 2016-05-21 Impact factor: 3.090